Izu Yayoi, Ezura Yoichi, Koch Manuel, Birk David E, Noda Masaki
Department of Molecular Pharmacology, Medical Research Institute, Tokyo Medical and Dental University, M&D Tower 24th, 5-45 1-Chome Yushima, Bunkyo-ku, Tokyo, 113-8549, Japan.
Institute for Dental Research and Musculoskeletal Biology, Center for Biochemistry, University of Cologne, Cologne, Germany.
Cell Tissue Res. 2016 Jun;364(3):623-635. doi: 10.1007/s00441-015-2345-y. Epub 2016 Jan 12.
Bone formation is precisely regulated by cell-cell communication in osteoblasts. We have previously demonstrated that genetic deletion of Col6a1 or Col12a1 impairs osteoblast connections and/or communication in mice, resulting in bone mass reduction and bone fragility. Mutations of the genes encoding collagen VI cause Ullrich congenital muscular dystrophy (UCMD) and Bethlem myopathy (BM), which have overlapping phenotypes involving connective tissue and muscle. Recent studies have identified COL12A1 gene mutations in patients with UCMD- and BM-like disorders harboring no COL6 mutations, indicating the shared functions of these collagens in connective tissue homeostasis. The purpose of this investigation has been to test the hypothesis that collagens VI and XII have coordinate regulatory role(s) during bone formation. We analyzed the localization of collagens VI and XII relative to primary osteoblasts during osteogenesis. Immunofluorescence analysis demonstrated that collagens VI and XII colocalized in matrix bridges between adjacent cells during periods when osteoblasts were establishing cell-cell connections. Quantification of cells harboring collagen bridges demonstrated that matrix bridges were composed of collagens VI and XII but not collagen I. Interestingly, matrix bridge formation was impaired in osteoblasts deficient in either Col6a1 or Col12a1, suggesting that both collagens were indispensable for matrix bridge formation. These data demonstrate, for the first time, a functional relationship between collagens VI and XII during osteogenesis and indicate that a complex containing collagens VI and XII is essential for the formation of a communicating cellular network during bone formation.
成骨细胞中的细胞间通讯精确调控着骨形成。我们之前已经证明,在小鼠中基因敲除Col6a1或Col12a1会损害成骨细胞的连接和/或通讯,导致骨量减少和骨脆性增加。编码胶原蛋白VI的基因突变会导致乌尔里希先天性肌营养不良(UCMD)和贝斯勒肌病(BM),它们具有涉及结缔组织和肌肉的重叠表型。最近的研究在没有COL6突变的UCMD和BM样疾病患者中发现了COL12A1基因突变,表明这些胶原蛋白在结缔组织稳态中具有共同功能。本研究的目的是检验胶原蛋白VI和XII在骨形成过程中具有协同调节作用这一假设。我们分析了在骨生成过程中胶原蛋白VI和XII相对于原代成骨细胞的定位。免疫荧光分析表明,在成骨细胞建立细胞间连接的时期,胶原蛋白VI和XII在相邻细胞之间的基质桥中共定位。对含有胶原桥的细胞进行定量分析表明,基质桥由胶原蛋白VI和XII组成,而不是胶原蛋白I。有趣的是,在缺乏Col6a1或Col12a1的成骨细胞中,基质桥形成受损,这表明这两种胶原蛋白对于基质桥形成都是不可或缺的。这些数据首次证明了在骨生成过程中胶原蛋白VI和XII之间的功能关系,并表明含有胶原蛋白VI和XII的复合物对于骨形成过程中通讯细胞网络的形成至关重要。